Bryan Tysinger

Bryan Tysinger

Auto-generated profile, based on publicly available information

Bryan Tysinger

Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2018 in The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences
Verified
Journal Article
Closed access
JZJulie M Zissimopoulos
Julie M Zissimopoulos
BTBryan C Tysinger
Bryan C Tysinger
PSPatricia A St.Clair
Patricia A St.Clair
ECEileen M Crimmins
Eileen M Crimmins
We assessed potential benefits for older Americans of reducing risk factors associated with dementia. A dynamic simulation model tracked a national cohort of persons 51 and 52 years of age to project dementia onset and mortality in risk reduction scenarios for diabetes, hypertension, and dementia. We found reducing incidence of diabetes by 50% did not reduce number of years a person ages 51 or 52 lived with dementia and increased the population ages 65 and older in 2040 with dementia by about 115,000. Eliminating hypertension at middle and older ages increased life expectancy conditional on survival to age 65 by almost 1 year, however, it increased years living with dementia. Innovation in treatments that delay onset of dementia by 2 years increased longevity, reduced years with dementia, and decreased the population ages 65 and older in 2040 with dementia by 2.2 million. Prevention of chronic disease may generate health and longevity benefits but does not reduce burden of dementia. A focus on treatments that provide even short delays in onset of dementia can have immediate impacts on longevity and quality of life and reduce the number of Americans with dementia over the next decades.

1 January 2019 in Alzheimer's & Dementia: Translational Research & Clinical Interventions
Verified
Journal Article
Open access
YCYi Chen
Yi Chen
BTBryan Tysinger
Bryan Tysinger
ECEileen Crimmins
Eileen Crimmins
JZJulie M. Zissimopoulos
Julie M. Zissimopoulos
Introduction: Medicare claims data may be a rich data source for tracking population dementia rates. Insufficient understanding of completeness of diagnosis, and for whom, limits their use. Methods: We analyzed agreement in prevalent and incident dementia based on cognitive assessment from the Health and Retirement Study for persons with linked Medicare claims from 2000 to 2008 (N = 10,450 persons). Multinomial logistic regression identified sociodemographic factors associated with disagreement. Results: Survey‐based cognitive tests and claims‐based dementia diagnosis yielded equal prevalence estimates, yet only half were identified by both measures. Race and education were associated with disagreement. Eighty‐five percent of respondents with incident dementia measured by cognitive decline received a diagnosis or died within the study period, with lower odds among blacks and Hispanics than among whites. Discussions: Claims data are valuable for tracking dementia in the US population and improve over time. Delayed diagnosis may underestimate rates within black and Hispanic populations.

17 November 2015 in Forum for Health Economics and Policy
Verified
Journal Article
Open access
PDF file
ÉGÉtienne Gaudette
Étienne Gaudette
BTBryan Tysinger
Bryan Tysinger
ACAlwyn Cassil
Alwyn Cassil
DGDana P. Goldman
Dana P. Goldman
On Medicare’s 50th anniversary, we use the Future Elderly Model (FEM) – a microsimulation model of health and economic outcomes for older Americans – to generate a snapshot of changing Medicare demographics and spending between 2010 and 2030. During this period, the baby boomers, who began turning 65 and aging into Medicare in 2011, will drive Medicare demographic changes, swelling the estimated US population aged 65 or older from 39.7 million to 67.0 million. Among the risks for Medicare sustainability, the size of the elderly population in the future likely will have the highest impact on spending but is easiest to forecast. Population health and the proportion of the future elderly with disabilities are more uncertain, though tools such as the FEM can provide reasonable forecasts to guide policymakers. Finally, medical technology breakthroughs and their effect on longevity are most uncertain and perhaps riskiest. Policymakers will need to keep these risks in mind if Medicare is to be sustained for another 50 years. Policymakers may also want to monitor the equity of Medicare financing amid signs that the program’s progressivity is declining, resulting in higher-income people benefiting relatively more from Medicare than lower-income people.

1 May 2018 in JACC: Heart Failure
Verified
Journal Article
Closed access
KNKaren E. Van Nuys
Karen E. Van Nuys
ZXZhiwen Xie
Zhiwen Xie
BTBryan Tysinger
Bryan Tysinger
MHMark Hlatky
Mark Hlatky
DGDana P. Goldman
Dana P. Goldman

1 April 2019 in Health Affairs
Verified
Journal Article
Closed access
SSSeth A. Seabury
Seth A. Seabury
SASarah Axeen
Sarah Axeen
GPGwyn Pauley
Gwyn Pauley
BTBryan Tysinger
Bryan Tysinger
DSDanielle Schlosser
Danielle Schlosser
DGDana P. Goldman
Dana P. Goldman
Serious mental illness (SMI) is a disabling condition that develops early in life and imposes substantial economic burden. There is a growing belief that early intervention for SMI has lifelong ben...

1 August 2017 in Medical Care
Verified
Journal Article
Closed access
PCPatricia ScB St. Clair
Patricia ScB St. Clair
ÉGÉtienne Gaudette
Étienne Gaudette
HZHenu Zhao
Henu Zhao
BTBryan Msc Tysinger
Bryan Msc Tysinger
RSRoxanna Seyedin
Roxanna Seyedin
DGDana P. Goldman
Dana P. Goldman
Background: Two common ways of measuring disease prevalence include: (1) using self-reported disease diagnosis from survey responses; and (2) using disease-specific diagnosis codes found in administrative data. Because they do not suffer from self-report biases, claims are often assumed to be more objective. However, it is not clear that claims always produce better prevalence estimates. Objective: Conduct an assessment of discrepancies between self-report and claims-based measures for 2 diseases in the US elderly to investigate definition, selection, and measurement error issues which may help explain divergence between claims and self-report estimates of prevalence. Data: Self-reported data from 3 sources are included: the Health and Retirement Study, the Medicare Current Beneficiary Survey, and the National Health and Nutrition Examination Survey. Claims-based disease measurements are provided from Medicare claims linked to Health and Retirement Study and Medicare Current Beneficiary Survey participants, comprehensive claims data from a 20% random sample of Medicare enrollees, and private health insurance claims from Humana Inc. Methods: Prevalence of diagnosed disease in the US elderly are computed and compared across sources. Two medical conditions are considered: diabetes and heart attack. Results: Comparisons of diagnosed diabetes and heart attack prevalence show similar trends by source, but claims differ from self-reports with regard to levels. Selection into insurance plans, disease definitions, and the reference period used by algorithms are identified as sources contributing to differences. Conclusions: Claims and self-reports both have strengths and weaknesses, which researchers need to consider when interpreting estimates of prevalence from these 2 sources.